| Nov 12 |
Schrödinger Reports Third Quarter 2024 Financial Results
|
| Nov 12 |
Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 4 |
Schrödinger to Present at Jefferies London Healthcare Conference
|
| Oct 31 |
Schrödinger to Announce Third Quarter 2024 Financial Results on November 12
|
| Oct 23 |
iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?
|
| Oct 23 |
Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium
|
| Oct 18 |
Schrödinger, Inc. Continues To Be A Complicated Story
|
| Oct 17 |
Schrödinger's Path Forward: AI, Cash Burn, And Clinical Uncertainty
|
| Oct 9 |
Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium
|
